Clinical Trials
2 trialsNCT04044950 2020-09-22
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT02382419 2019-08-01
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Rutgers, The State University of New Jersey
Phase 2 Withdrawn